Navigation Links
Kibow Biotech Marks Its Continued Growth with Relocation to Larger Facilities
Date:7/31/2012

NEWTOWN SQUARE, Pa., July 31, 2012 /PRNewswire/ -- Kibow Biotech Inc. (KIBOW) is pleased to announce its recent relocation to a custom-built probiotic R&D center dedicated to the development and commercialization of natural formulations (mainly targeting renal failure). The new 7500 sq. ft. center is located at 4781 West Chester Pike, very close to the Company's previous operations at 4629 West Chester Pike in the same Newtown Square, PA area. For Kibow, the custom-built R&D facility and new office space means expanded research operations and also improved client service, new amenities for employees and room for growth.

The facility includes 2500 sq. feet of R&D lab space divided into six separate labs with a large office work area for the lab staff. Each lab is fully equipped with the necessary operational equipment, instruments and safety facilities in compliance with local, state and federal regulations, as well as with the Occupational Safety Hazard Authority (OSHA) ordinances. The rest of the 5000 sq. ft. area is comprised of six corporate management offices, several well-designed cubicles for sales, marketing and customer service staff, a state-of-the-art web and teleconference & lunch room and a combined cold room and shipping facilities.

"As a consequence of the positive market reaction to our recent introduction of Renadyl™ (http://www.Renadyl.com) for kidney compromised patients, and in view of the continued success of Azodyl™, our animal formulation under world-wide license to Vetoquinol, SA (http://www.vetoquinolusa.com), we needed to expand. We were fortunate to find an appropriate space so close to our previous office. We really wanted to limit the impact that relocation could have on our clients and our employees. I don't think we could have found a better location for our team. Our new location and enhanced operational effici
'/>"/>

SOURCE Kibow Biotech Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. GenWay Biotech Appoints New Vice President of Custom/OEM
2. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
7. Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June
8. Tougher Times May be Ahead for Biotechs: 1H12 Fundraising Slows
9. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Lifeline Biotechnologies First Warning Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... SAN DIEGO , May 17, 2013 /PRNewswire/ ... today that its Fast-Track Advanced Technology Small Business ... National Institute of Allergy and Infectious Diseases (NIAID), ... (NIH), supporting the development of novel human antibody ... S. aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... 2013  Technology advances have had a profound ... a constantly evolving communication environment, companies need to ... with internal executives. It is challenging, however, to ... and tools that are part of today,s communication ... Best Practices, LLC explores the various internal communication ...
(Date:5/17/2013)... May 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... holder and 130um sorting chip.  Sony will also be exhibiting ... new SH800 Cell Sorter, the EC800 flow cytometer, and new ... CYTO 2013, which will be held at the ... Diego, California , from May 20 - 22.  ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Delivers New Technology for Science to CYTO 2013 2
... CITY, Utah, Nov. 4, 2010 NuView Life ... the development of proprietary target specific biomarkers for ... announced today that its applications for the Qualifying ... The grants totaling just over ...
... SALT LAKE CITY, Nov. 4, 2010 ... Mrs. Carla Peacock, from Wylie, Texas. Peacock has eleven years ... Texas, where she audits workers, compensation bills. She was curious ... decided, with the encouragement of her employer, to learn medical ...
Cached Medicine Technology:NuView Life Sciences Awarded Grants Under the Patient Protection and Affordable Care Act of 2010 2AAPC Reaches 100,000 Members 2
(Date:5/19/2013)... Seattle, Wa (PRWEB) May 19, 2013 Agora ... training program that covers guides on how to increase ... an innovative memory training method that helps people re-new their ... fight stress and beat depression caused by a fatigued mind. ... their mind razor sharp for a lifetime. The author claimed ...
(Date:5/19/2013)... 2013 Beginning Wednesday, May 29 and running ... (RRVBC) will feature “Hot Dog Wednesdays" and Ice Cold Slushies ... provide hot dogs and all the fixin's to donors on ... throughout the summer. “Donors are our lifeline. The summer months ... adequate blood supply. This is a small way for ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
(Date:5/19/2013)... The Da Vinci robot lawyers at Wright ... nation’s first trial involving a Da Vinci surgical robot ... Court, was filed by the widow of a man ... a robot-assisted prostate removal, according to a report from ... lawsuit alleges those complication’s hastened his death. (Estate ...
(Date:5/18/2013)... Daily Gossip issued a press release last week to announce ... Colston, Daily Gossip’s spokesperson, told the press that the magazine ... Fat Loss Plan . , Shaun Hadsall was the ... time when nutritionists and fat loss gurus constantly told people ... diet is based on the Macro-Patterning scheme, according ...
Breaking Medicine News(10 mins):Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... SHANGHAI, Sept. 1 /PRNewswire-Asia/ -- Linkwell ... distributor,of healthcare-related disinfectants in China, put forward its worries ... spread of H1N1. , "Antisepsis ... and control,infectious diseases, and it will work best when ...
... , , BARCELONA, Spain, ... in patients treated with LIVALO (pitavastatin), high-density lipoprotein cholesterol ... low-density lipoprotein cholesterol (LDL-C) targets, with results sustained over ... efficacy to atorvastatin and simvastatin, as measured by reduction ...
... last spring , MONDAY, Aug. 31 (HealthDay News) -- As ... campuses, school administrators are beefing up efforts to encourage students ... further. , Signs popping up on campuses across the ... to take the flu seriously, to get seasonal flu shots, ...
... drive within two hours , TUESDAY, Sept. 1 (HealthDay News) ... behind the wheel and drive within two hours of drinking, ... timeline and other new information to what,s known about drinking ... with the alcohol team at the U.S. Centers for Disease ...
... , CHICAGO, Sept. 1 Controlling healthcare costs seems like ... to save our nation billions of dollars. , , ... to Jason Beans, CEO of Chicago-based Rising Medical Solutions , is ... in a different direction. , , "People debate whether ...
... , , , COLUMBUS, ... support for Childhood Cancer Awareness Month by kicking off a new integrated ... Disorders Service of Children,s Healthcare of Atlanta . Childhood cancer is ... age of 15. Through improved research and treatments, childhood cancer survival rates ...
Cached Medicine News:Health News:Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine? 2Health News:Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine? 3Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 2Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 3Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 4Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 5Health News:Swine Flu on Campuses Boosts Call for Vaccinations 2Health News:Driving After Binge Drinking More Common Than Believed 2Health News:Driving After Binge Drinking More Common Than Believed 3Health News:Five Ways to Change America's Healthcare System: 2Health News:Aflac Announces Support for Childhood Cancer Awareness Month 2Health News:Aflac Announces Support for Childhood Cancer Awareness Month 3Health News:Aflac Announces Support for Childhood Cancer Awareness Month 4Health News:Aflac Announces Support for Childhood Cancer Awareness Month 5
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
Helmer's Horizon Series line of refrigerator is designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety o...
... the i.Series refrigerator iB120, ... for the blood bank. ... than ever before, i.Series ... at the forefront of ...
... Designed for the precise requirements of ... Forma Blood Bank Equipment meets American ... National Red Cross (ANRC) and U.S. ... Refrigerators, storage freezers, and platelet incubators ...
Medicine Products: